| Dr Bradford Elrod Mutchler, MD | |
|
1219 N. Main St, Beaver Dam, KY 42320 | |
| (270) 274-1800 | |
| (270) 274-5600 |
| Full Name | Dr Bradford Elrod Mutchler |
|---|---|
| Gender | Male |
| Speciality | Preventive Medicine - Occupational Medicine |
| Location | 1219 N. Main St, Beaver Dam, Kentucky |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1679792196 | NPI | - | NPPES |
| 64133945 | Medicaid | KY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2083X0100X | Preventive Medicine - Occupational Medicine | 13394 (Kentucky) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Bradford Elrod Mutchler, MD 1219 N. Main St., Beaver Dam, KY 42320 Ph: (270) 274-1800 | Dr Bradford Elrod Mutchler, MD 1219 N. Main St, Beaver Dam, KY 42320 Ph: (270) 274-1800 |
News Archive
Family history, infection and stress all may play a role in raising a woman's risk of having a premature baby - but they don't fully explain why some women give birth too soon and others don't, according to a review article published today in the New England Journal of Medicine.
They make up less than one-hundredth of 1 percent of the microbes that live in the colon, but the bacteria and archaea that sop up hydrogen in the gut are fundamental to colon health. In a new study, researchers take a first look at these "hydrogenotrophic" microbes, mapping where they live and how abundant they are in different parts of the lower intestine.
BioSante Pharmaceuticals, Inc. today announced the receipt of two US new patents directed to its 2A/Furin technology for expressing proteins. The first issued US patent, US Pat. No., 7,709,224, covers methods for manufacturing recombinant antibodies. By incorporating our 2A/Furin technology into antibody-expression in viral vectors it is possible to rapidly generate stable, high producing antibody cell lines.
When a fall, car crash, bullet, or knife crushes or cuts a spinal cord, the injury does not stop there. Rather, tissues continue to discharge toxic chemicals for hours, even days and weeks. These chemicals kill and disable nerve cells some distance away from the core injury, compounding the damage and making rehabilitation more difficult or impossible.
Invida Group Pte Ltd, the leading specialty pharmaceutical company focused on the commercialization of healthcare products throughout Asia Pacific, today announced that it has entered into a partnership agreement with Roche for the commercialization and marketing of that company's primary care portfolio throughout Korea.
› Verified 2 days ago